H
Helle Wallach Kildemoes
Researcher at University of Copenhagen
Publications - 17
Citations - 2156
Helle Wallach Kildemoes is an academic researcher from University of Copenhagen. The author has contributed to research in topics: Population & Drug Utilization. The author has an hindex of 10, co-authored 17 publications receiving 1731 citations. Previous affiliations of Helle Wallach Kildemoes include University of Southern Denmark & Danish Medicines Agency.
Papers
More filters
Journal ArticleDOI
The Danish National Prescription Registry
TL;DR: The possibility of linkage with many other nationwide individual-level data sources renders the DNPR a very powerful pharmacoepidemiological tool.
Pharmaceutical regulation in 15 European countries review.
Dimitra Panteli,Francis Arickx,Irina Cleemput,Guillaume Dedet,Helene Eckhardt,Emer Fogarty,Sophie Gerkens,Cornelia Henschke,Jenni Hislop,Claudio Jommi,Claudio Jommi,Daphne Kaitelidou,Paweł Kawalec,Ilmo Keskimäki,Madelon Kroneman,Julio Lopez Bastida,Pedro Pita Barros,Joakim Ramsberg,Peter Schneider,Susan Spillane,Sabine Vogler,Lauri Vuorenkoski,Helle Wallach Kildemoes,Olivier J. Wouters,Reinhard Busse +24 more
TL;DR: Investigation of a broad range of regulatory measures, spanning marketing authorization to generic substitution and resulting price levels in a sample of 16 European health systems finds no definitive evidence has yet been produced on the effects of different cost-containment measures on patient outcomes.
Journal ArticleDOI
The impact of population ageing on future Danish drug expenditure.
Helle Wallach Kildemoes,Terkel Christiansen,Dorte Gyrd-Hansen,Ivar Sønbø Kristiansen,Ivar Sønbø Kristiansen,Morten Andersen +5 more
TL;DR: The results of the study indicate that Danish policies aimed at limiting the increase in public drug expenditure should focus on rational pharmacotherapy and on the promotion of prescription of cost-effective pharmaceuticals-rather than targeting the drug use of the elderly or reducing the reimbursement generally.
Journal ArticleDOI
Statin utilization according to indication and age: a Danish cohort study on changing prescribing and purchasing behaviour.
TL;DR: While patent expiry and lower prices most likely boosted the general increase in statin utilization, the gradually altered indication and age pattern seems to be driven by guidelines, influencing both reimbursement rules and general healthcare policies.
Journal ArticleDOI
Drug utilization according to reason for prescribing: a pharmacoepidemiologic method based on an indication hierarchy.
Helle Wallach Kildemoes,Helle Wallach Kildemoes,Carsten Hendriksen,Morten Andersen,Morten Andersen +4 more
TL;DR: To develop a pharmacoepidemiologic method for drug utilization analysis according to indication, gender, and age by means of register‐based information, using Statin utilization in 2005 as an example.